15 March 2022 COVID-19 vaccination study opens at Great Ormond Street Hospital Patients at Great Ormond Street Hospital and Southampton Children's Hospital are taking part in research to work out how they respond to COVID-19 vaccination.
26 August 2021 New study to test third COVID-19 vaccine for people with weakened immune systems A new clinical trial has launched in the UK to determine whether a third vaccine will improve the immune response of people who have weakened immune systems.
24 August 2021 Study shows low or undetectable immune response to double COVID-19 vaccination in patients with impaired immune systems A significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions mount a low or undetectable immune response after two doses of the same COVID-19 vaccine
04 August 2021 World-first UK trial to assess whether cannabis-based drug could extend life for thousands with aggressive brain tumours The University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
29 June 2021 Blood cancer trial sponsored by the University of Birmingham opens for recruitment A new clinical trial being sponsored by the University of Birmingham has opened for recruitment aiming to investigate the efficacy of a novel treatment for patients affected by a specific type of blood cancer.
10 May 2021 Bayer to invest in childhood cancer trial at the University of Birmingham Funding from Bayer enables the University of Birmingham to deliver a new study aiming to identify more effective treatments for a rare type of childhood cancer.
03 March 2021 New study launches into COVID-19 vaccine responses in patients with impaired immune systems A UK study sponsored and run by the University of Birmingham has launched aiming to better understand the immune response to COVID-19 vaccinations in patients with certain immunosuppressed conditions including cancer.
29 January 2021 Birmingham Brief: What happened to cancer while COVID-19 took the front seat? Professor Pam Kearns, Director of the Institute of Cancer and Genomic Sciences, writes an opinion piece on how COVID-19 has replaced cancer as 'the big C'.
05 January 2021 Cancer Research UK appoints new Trustee from the University of Birmingham Cancer Research UK has announced the appointment of Professor Pamela Kearns, Director of the University of Birmingham's Institute of Cancer and Genomic Sciences, as a Trustee and Member.
12 May 2020 Major COVID-19 drugs trial begins in Birmingham A trial which will rapidly test new therapies for patients hospitalised due to COVID-19 is opening in Birmingham this week.
25 October 2019 Leading neurosurgeon highlights importance of brain tumour research Professor Colin Watts, Chair of the Birmingham Brain Cancer Program, highlights the importance of brain tumour research.
13 May 2019 £1.3 million awarded by the MRC to find new treatments for leukaemia Scientists at the University of Birmingham and Newcastle University have teamed up to develop new ways of treating different classes of Acute Myeloid Leukaemia (AML) carrying specific gene mutations.
